NovaBridge Biosciences (NBP) EBT (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly EBT of -$72.9 million for Q4 2025, down 571.87% year-over-year from $15.4 million in Q4 2024, and down 967.05% quarter-over-quarter from -$6.8 million in Q3 2025.
Powered by 
Analysis
NovaBridge Biosciences (NBP) EBT (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported EBT for 5 consecutive years, with -$72.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, EBT fell 571.87% year-over-year to -$72.9 million; the TTM figure through Dec 2025 stood at -$88.3 million (down 77.76% YoY), while the FY2025 annual figure was -$88.3 million, down 77.76% from the prior year.
- EBT retreated to -$72.9 million in Q4 2025 per NBP's latest filing, from -$6.8 million in the prior quarter.
- Across five years, EBT topped out at -$3.2 million in Q1 2025 and bottomed at -$72.9 million in Q4 2025.
- Historically, EBT has averaged -$19.2 million across 3 years, with a median of -$9.4 million in 2024.
- Annual changes were most pronounced in 2024 — EBT jumped 70.62% — and 2025, when it slumped 571.87%.
- NovaBridge Biosciences' EBT stood at -$36.9 million in 2023, then surged by 70.62% to -$10.8 million in 2024, then plunged by 571.87% to -$72.9 million in 2025.
- Business Quant data shows NBP's EBT at -$72.9 million in Q4 2025, -$6.8 million in Q3 2025, and -$5.5 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 542.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -767.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 312.46 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 177.81 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -11.37 Mn |
| 10 | NovaBridge Biosciences | 197.68 Mn | 197.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -88.34 Mn |
| Sep 30, 2025 | 8.65 Mn |
| Jun 30, 2025 | -5.50 Mn |
| Mar 31, 2025 | -3.15 Mn |
| Dec 31, 2024 | -49.70 Mn |
| Sep 30, 2024 | -20.49 Mn |
| Jun 30, 2024 | -8.94 Mn |
| Mar 31, 2024 | -9.42 Mn |
| Dec 31, 2023 | -36.91 Mn |
| Sep 30, 2023 | -8.22 Mn |
| Jun 30, 2023 | -27.56 Mn |
| Dec 31, 2020 | 159.01 Mn |
| Sep 30, 2020 | 1.77 Mn |
| Dec 31, 2019 | -49.46 Mn |
| Sep 30, 2019 | -35.10 Mn |